The latest states to join us on our quest for consciousness freedom are Florida and New Jersey, who have taken the next steps in clinical trials of entheogens. Oregon also just officially decriminalized all drugs and replaced jail time with a $100 fine for public possession or intoxication, along with a health assessment for addiction and mental health issues, which seems like a healthier step in the right direction.

Among the first casualties of the psychedelic revolution is MindCure Health (MCURF), which was focused on mental health and wellness. The company’s CEO, Philip Tapley announced they were shutting down operations due to a lack of funding and decided to immediately eliminate all expenditures outside those required to preserve the value of the Company's assets.

Previous studies have shown that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.

In the past 12 months, Cybin has expanded the psychedelic organization to more than 55 employees across four countries and has established partnerships with over 50 participants in the psychedelic industry.

The U.S. Food and Drug Administration has authorized The Peter Thiel-Backed Psychedelics Company German psychedelics startup Atai Life Sciences to conduct a clinical trial on a nonpsychedelic form of ketamine for treatment-resistant depression.

Detroit has joined the growing number of cities and states that have decriminalized entheogenic plants and fungi, known as “magic mushrooms” and psychedelics. Voters, including the city’s incumbent mayor who won a re-election, passed Proposal E on Tuesday night to decriminalize entheogenic plants and fungi.

The Harvard Law School's Petrie-Flom Center for Health Law policy, biotechnology, and bioethics announced Wednesday that it is launching the first academic initiative focused on psychedelics law and policy, The Project on Psychedelics Law and Regulation, known as POPLAR.

Field trip health has opened a brand-new facility in Houston, Texas and is moving forward with ketamine therapies for veterans. Field Trip plans to provide MDMA-assisted psychotherapy to veterans with PTSD as soon as the FDA approves these psychedelic substances for therapeutic use.

Another Massachusetts city has approved a measure to deprioritize enforcement of laws against the possession, use and distribution of a wide range of psychedelics such as psilocybin and ayahuasca.

The California activism group, decriminalize nature, pushes forward with psychedelic decriminalization.

Silo Wellness has recently gone public on the Canadian Securities Exchange. After launching a psilocybin nasal spray for Micro-Dosing, and psychedelic retreat centers in Jamaica and Oregon, Silo is currently only trading at 0.24 Cents per share!

UNLV neuroscientist Dustin Hines and wife Rochelle Hines are uncovering how psychedelics affect brain activity at the Hines Lab at the UNLV campus.

Don’t Miss Our Newest Episode of The SykoActive Entheogens Podcast, Dropping Tomorrow Morning at 7:00 a.m. SykoActive is speaking with Sarah Hope, a spiritual teacher, professional life coach and certified nature retreat leader. She is an interfaith minister, ceremonialist and trained guide of entheogenic journeys. Sarah started the Forest Medicine Coaching service, to coach healers about the benefits natural plant medicines and how to integrate psychedelics into their existing practice.

40 kilograms of “Magic” Psilocybin Mushrooms will be dried and shipped to Mydecine’s Canadian Current Good Manufacturing Practice facility, which has a Health Canada Schedule 1 Dealer’s License attached to it, allowing for legal import/export, research and development, cultivation, and commercial sale of active psychedelic medicinal compounds.

Washington Representatives Lauren Davis (D) and Kirsten Harris-Talley (D) introduced Washington Bill HB 1499. This Legislature would make Washington the second state in the nation to legalize the personal use of all drugs, ranging from psychedelic mushrooms to opiates. The measure would also designate state money into treatment and community-based intervention programs, where drug users and people with mental health problems would be referred instead of being treated like a criminal and going to jail.

PharmaTher is a specialty life science company focused on the research and development of psychedelics. They have recently filed patents with the FDA to mix FDA approved neurological drugs with Ketamine, Psilocybin, Cannabis, and MDMA to treat neurological disorders using GelMA micro-needle technology and transdermal patches.

On February 18th 2021, A Democrat from San Francisco, California introduced a bill to decriminalize psychedelics on a state level. Senator Scott Wiener introduced Senate Bill 519 to decriminalize certain psychedelics in the interest of public health and safety and to address the failed War on Drugs.

Investors are supporting the psychedelic industry with millions being donated to the Capstone Campaign, a psychedelic research fundraising campaign. Magic mushrooms and other psychedelics entheogens soon will be mainstream medicinal alternatives for mental and emotional health issues.

Minerco Magic Mushroom Company Releases SHRU Cryptocurrency and is about to press 1 million psilocybin micro-tablets!

The Psychedelic Science Funders Collaborative or PSFC is leading the community of philanthropists funding psychedelic research and supporting psychedelic medicine. PSFC identifies and assesses funding opportunities for its members, provides ongoing support for its funding partners, and facilitates relationships and education about psychedelic research within the philanthropic community.